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Jefferson
and Nemours
Partnering Today
for Healthier
Tomorrows

Downsizing?

Facing Capital Gains?
Donate your property — or a portion of it — to Jefferson.
Do you have property that is a burden to manage?
Do you own property you don’t use anymore?
Will you owe significant taxes if you sell your property?
If so, the Jefferson Foundation can help. By donating real estate
to Jefferson, you can achieve peace of mind, create a lasting legacy
and receive financial benefits for yourself or someone else.

What’s in it for you?

Depending on the nature of your gift and your objectives,
you could:
• Avoid capital gains taxes on appreciated property.
• Eliminate the burden of maintaining and paying
for the property.
• Provide yourself with an annual income.
• Reduce your estate and income taxes.
The Jefferson Foundation staff will gladly discuss
the various giving options associated with gifts
of property and real estate. For more information
contact Fritz Ruccius at the Jefferson Foundation,
215-955-8733 or frederick.ruccius@jefferson.edu.
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The Dean’s Column
Many institutions are guided by a sense
of self-sufficiency. A “we-can-do-it-alone”
mentality frames their approaches to all
sorts of things — from closed-shop hospital
staffing to lopsided inter-institutional
partnering formulas. Other institutions are
wired differently — imbued instead with
a sense that “going-it-alone is not the best
option,” and that so much more is to be
gained from robust collaboration and interconnectedness. Reaching out to multiple
partners, even in creative ways to titular
‘competitors,’ becomes a preferable starting
point. For these institutions, Jefferson
among them, ‘partnership’ is a core
value proposition.
We believe that training physicians of
the future demands partnerships. True, the
Medical College’s historically large class
size has made alignment with multiple
teaching affiliates an imperative. However,
this is only part of the logic that has driven
Jefferson’s historical openness to partners.
Multiple training sites translate into a rich
training experience for each individual
student. Attending physicians ensconced in
diverse practice settings create a tapestry
of clinical acumen for our students to draw
upon. And the benefits of Jefferson’s propartnership ethos spillover amply into its
research and clinical missions as well.
The Jefferson collaboration mindset
touches a multiplicity of specialties, disciplines and sites. Several of these concentric
‘partnership spheres’ stand out.
First, three prestigious, world-class
institutions — Nemours/Alfred I. duPont
Hospital for Children, Wills Eye Institute
and Rothman Institute — serve as Jefferson’s
Pediatrics, Ophthalmology and Orthopaedics
departments, respectively (please see page 6
for Nemours partnership feature story).
Most medical schools would find it hard to

even conceive of three core clinical departments such as these sitting outside their
‘financial control orbit’ — but not so for
JMC. We simply leverage their greatness
and ensure that all boats rise together. The
fact that these institutions share a visceral
commitment to all elements of the tripartite
mission makes this easy.
Second, a web of alliance partners —
Main Line Health System, Christiana Care
Health Systems in Delaware, Virtua Health
System in New Jersey, Albert Einstein
Medical Center in Philadelphia, Reading
and York Hospitals, among them — form
the backbone of our clinical training
programs. Approximately 50 percent of
our third- and fourth-year students are
in training at these affiliated institutions
at any one time. There they receive the
same superb education that they would
have received at the Center City campuses,
thanks to our dedicated faculty. We
emphasize open communication with
our affiliate faculty members and meet
with them regularly to review curricular
changes, thus ensuring that the education
our students receive on any rotation is
equally rich at all sites.
Third, other regional universities are
part of Jefferson’s universe of academic and
research partnerships. There is a robust and
growing set of links between Jefferson and
the University of Delaware. We have served as
the medical school for the State of Delaware
for many years, and UD has been a linchpin
in our mission-critical bridge to Delaware,
alongside Christiana Care and Nemours. In
fact, our four institutions have in recent years
been knitted together under the banner of the
Delaware Health Sciences Alliance.
Another exciting university partnership
has been cultivated with Drexel University.
Most notably, Drexel’s School of Medicine

was brought into Jefferson’s Kimmel Cancer
Center, in the course of the recent cancer
center core grant renewal by the National
Cancer Institute. This represents a most
significant development — a wonderful
example of two medical schools in one city
coming together for a common academic
purpose. Now, Drexel and Jefferson scientists alike can benefit from the research
core support that KCC has to offer. With
outstanding leaders at the helms of their
university and medical school, we are
poised to explore additional collaborative
opportunities with Drexel. In these resourceconstrained times, institutions that were
once pitted as ‘competitors’ can sometimes
be better served by re-imagining themselves
as partners — a new take on the coined term
‘coopetition’, or cooperative competition.
Much is said in the press about the
necessity to be ‘competitive’ in all spheres
of 21st century human endeavor. Our
nation is asked to be more competitive
when facing off against other countries.
Our healthcare institutions are asked to
be more competitive in matching up
against other regional and national
players. But paradoxically perhaps, in
some instances competitiveness may
actually be enhanced by cooperation and
redefining whom the competition really
is out there. Historically, cooperation has
proved good for Jefferson and its missions.
Looking to the future, it also bodes well
for the greater good.

Mark L. Tykocinski, MD
Anthony F. and Gertrude M. DePalma Dean
Jefferson Medical College
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We believe that training
physicians of the future
demands partnerships.
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Findings
Targeting Dual Roles of PARP-1 May Slow Cancer Growth
A newly discovered function of the enzyme
PARP-1 could be the key to more effective
therapeutics for advanced prostate cancer
patients, a recent preclinical study by
researchers at Jefferson’s Kimmel Cancer
Center suggests.
The team, led by Karen Knudsen, PhD,
professor in the Department of Cancer
Biology, found that functions of PARP-1
not only include DNA damage repair but
also androgen receptor (AR) regulation
in advanced prostate cancer growth and
progression. Inhibiting PARP-1 in
various models, the researchers found,
also suppressed AR activity, which fuels
prostate growth.
Researchers believe that the dual function
of PARP-1 — both AR and DNA damage
function — could be leveraged for therapeutic
benefit. New PARP-1 inhibitors targeting both
could slow down advanced-stage prostate
cancer patients and shrink tumors, the team
surmises.
“We hope to capitalize on this previously
unknown function in PARP-1 in prostate
cancer,” Knudsen says. “Our data show that
PARP-1 plays a major role in controlling AR
function and that, when suppressed with
inhibitors, enhanced anti-tumor effects of
castration and delayed onset to castration
resistance. This is the basis to support a

clinical trial investigating new PARP-1
inhibitors in these patients.”
Today, PARP-1 is seen as a valuable target
because of its involvement in DNA repair for
cancer cells. The therapy has been successful
when combined with DNA-damaging drugs
because it heightens the apoptotic activity
of these drugs. In other words, it helps halt
tumor growth, but only by stopping DNA
repair in various cancers.
Prostate cancer is dependent on AR
activity for growth and survival, and is
largely resistant to standard chemotherapy.
AR-directed therapies are the first-line
intervention for patients with advanced
disease; however, recurrent tumors arise when
AR is reactivated, a common occurrence in
the castrate-resistant stage of the disease.
Therefore, there is a dire need to develop
means to suppress the AR function in these
patients. With this new role defined, newly
designed PARP-1 inhibiters targeting both
functions could sensitize prostate cancer,
so AR-directed therapies can perform their
intended function in these patients, the
researchers suggest in the paper.
Almost 40 percent of men with prostate
cancer progress into an advanced stage,
including castrate-resistant prostate cancer,
where chemotherapy and other therapies have
little to no effect.

One of the functions of the PARP-1 enzyme
is illustrated to show how it plays a role in
the repair of damaged DNA in cancer cells.

PARP-1 is recruited
to the location of
the DNA damage.

Using various in vitro and in vivo
genetically defined model systems and
applying an analysis known as ChIP
sequencing, the researchers found that
PARP-1 activity is required for AR function
and is increased in castrate-resistant prostate
cancer. What’s more, inhibiting PARP-1
suppressed proliferation of primary human
cancer cells.
“These findings introduce a paradigm shift
with regard to PARP-1 in prostate cancer,”
Knudsen says, “and provide the basis for new
therapies that could help a whole population
of cancer patients who have little options.”
Faculty from across Jefferson participated
in the study, with key co-authors including
Leonard Gomella, MD, chair of the
Department of Urology; Peter McCue, MD,
professor in the Department of Pathology,
Anatomy and Cell Biology; Jonathan Brody,
PhD, assistant professor in the Department of
Surgery; John Pascal, PhD, assistant professor
in the Department of Biochemistry and
Molecular Biology; and Adam Dicker, MD,
PhD, chair of the Department of Radiation
Oncology. A P01 grant to fund future clinical
trials is pending and will support the work of
Jefferson’s team as well as researchers from
the University of Michigan and Memorial
Sloan Kettering Cancer Center.

The PARP-1 enzyme
repairs the damaged
DNA, resulting in cell
proliferation and
tumor growth.

Researchers have found
that treating a patient
with a PARP-1 inhibitor
results in an increase in
cancer cell death.
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A newly discovered function of the PARP-1
enzyme is its protumorigenic effects in the
androgen receptor (AR) of positive prostate
cancer cells. Prostate cancer is dependent
on AR activity for growth and survival and
is resistant to standard chemotherapy. The
illustration shows how the process of AR
function and the PARP-1 enzyme work together
to grow and regenerate the cancer cell.
AR

Androgenic hormones
such as testosterone or
dihydrotesterone found
in the cellular wall bind with
the androgen receptor and
begin translocation, or the
process of the AR moving
into the cell nucleus.

Once in the nucleus,
the PARP-1 enzyme
is recruited to the site
of AR function.

PARP-1

PARP-1 enzymatic activity is increased. The
process of transcription* of the DNA occurs
— a vital event in the life of the cell — and the
cancer cell survives.
Research has shown that the inhibition of
the PARP-1 enzyme stops the AR activity,
preventing the cell from surviving the
damaging effects of chemotherapy.

*Transcription (n)
The process by which messenger RNA is
synthesized from a DNA template resulting
in the transfer of genetic information from
the DNA molecule to the messenger RNA.
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Jefferson and Nemours:

Partnering for Pediatric Patients
A vision of seamless transition to adult care
By Gail Luciani

I

magine you just turned 21. You have
had ulcerative colitis since you were 8.
It has been closely managed by your
pediatricians, but now that you are an adult,
they can no longer treat you. Your condition hasn’t gone away — but your medical
support team has. What do you do? Where
do you go for your healthcare needs?
“The department of pediatrics at Nemours/
Alfred I. duPont Hospital for Children is
actually the academic home for pediatrics
at Jefferson,” says Jay Greenspan, MD,
professor and chair, Department of Pediatrics.
“At the same time, Jefferson has incredibly
strong divisions like gastroenterology. So
for our pediatric patients with ulcerative
colitis or who are diagnosed with liver
failure and have a transplant at Nemours,
the obvious place for the next stage of their
care is Jefferson. But that handoff doesn’t
exist today — so our goal is to help these
Story Summary
Nemours/Alfred I. duPont Hospital
for Children is the academic home for
pediatrics at Jefferson.
	Working closely together, the two
institutions provide high-quality
pediatric care to the region’s children
both in Wilmington and at a satellite
pediatrics site in Philadelphia.
	Seamlessly transitioning pediatric
patients to Jefferson will benefit the
hospitals and patients alike.
	The launch of a new women and
children’s service line represents a
renewed focus on the future of health
care for both women and children
at Jefferson.

patients make a smooth transition to
adult care.”
Thirty Years of Partnering
Pave the Way

Located in Wilmington, Del., Nemours
began partnering with Jefferson in the
early 1980s. Pediatrics is a core element
of medical education, but at that time,
the Jefferson pediatrics department was
limited. Delaware had Nemours, a stellar
pediatrics hospital located just a few miles
south of Philadelphia on Interstate 95, but
it didn’t have a medical school. Partnering
answered the needs of both organizations.
Today, Jefferson serves as the medical
school of Delaware, and its students train at
the department of pediatrics at Nemours.
“Students are very much embedded in
day-to-day patient care,” says Greenspan.
“The six-week pediatrics rotation is usually
at Nemours, which has the largest patient
base in the Jefferson system.* Students are
our eyes and ears, and they present patient
cases first in rounds.” In addition to
training students on rotation, Nemours
provides clinical experience for pediatric
residents and fellows.
“The relationship is incredibly important
for both sides,” says Greenspan. “For
Jefferson, it allows us to train effectively
with an appropriate caseload, which
reinforces our reputation as a top-notch
medical school, and for Nemours, it provides
the opportunity to have a connection with a
major academic medical center.”
Nemours and Jefferson collaborate on
multidisciplinary pediatric programs for

chronic or complex medical conditions,
partner on important research studies
and coordinate care as needed, such as
facilitating the transfer of extremely ill
patients from Jefferson to Nemours.
“It’s a vital relationship that both
Jefferson and Nemours can be proud of,”
says Kevin Churchwell, MD, chief executive
officer for Nemours. “The continued development of our relationship is important for
pediatrics in this region and nationally.
Any way you look at it — from an academic
standpoint, a patient-service standpoint or
a research standpoint, Nemours being the
pediatric home for Jefferson creates a great
environment for success.”
A significant challenge for the two
partners is the 25-mile distance between
campuses. “We’re working on improving
communication and collaboration to help
solve that obstacle,” says Churchwell.
“We want to be more intentional about how
we continue to support clinical program
development, academic development and
research development.”
“The challenge of our physical distance
from each other is one that we will never
be able to change,” agrees Greenspan. “But
we can overcome that hurdle as people
recognize how strong both partners are in
this relationship and how important it is to
the future of both institutions to strengthen
that relationship.”
Working closely together, the two
institutions provide pediatric care to the
region’s children both in Wilmington and
at a satellite pediatrics site in Philadelphia.
“By aligning our strategies and leveraging

*Other affiliate institutions where students train include Main Line Health System, Virtua Health System, Albert
Einstein Medical Center, Christiana Care Health System, Reading Hospital and York Hospital.
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Jay Greenspan, MD, with a newborn at
Nemours. Photo by Cynthia Brodoway,
courtesy of Nemours/Alfred I. duPont
Hospital for Children.
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“The continued development
of our relationship is important
for pediatrics in this region
and nationally.”	 
—Kevin Churchwell, MD
Chief Executive Officer, Nemours

institutional strengths, we are advancing
the care of children both at Nemours and
on the Jefferson campus,” explains Pauline
Corso, practice administrator at Nemours.
Women and Children Service
Line Launched

In June 2012, Jefferson launched “women
and children,” its sixth service line. An
outcome of long-term strategy planning, it
was born of a newfound focus on the future
of health care for both women and children.
Initiatives are currently in the development
stage and include the participation of
Nemours as the primary practice site for
pediatrics. “All of our discussions start with
‘What’s best for the patients?’ then we work
backwards to deal with logistical challenges.
For example, which services should be on
the Philadelphia campus, and which should
be in Wilmington? Managing the geographic
distance between the two campuses is a
significant part of the discussion,” says
William Schlaff, MD, the Paul A. and
Eloise B. Bowers Professor and chair of the
Department of Obstetrics and Gynecology.
“And within a local context, we need to
address programs like the expansion of
obstetrical services and how that impacts
pediatrics and neonatal intensive care.”
New perinatal programs will go beyond
re-engineering obstetrics at Jefferson, given
the opportunity to collaborate across the
organization. “High-risk obstetrics tends
to focus on caring for the fetus, and not
the sick mother. So one of the initiatives
we are looking at is integrating with the
Department of Medicine to treat women
with medical problems who are pregnant

or who want to become pregnant,” says
Schlaff. “We want to be the place that takes
care of these patients most safely. By defining
most of our initiatives as multidisciplinary —
having the support of medicine, cardiology,
neonatal ICUs and other specialties — we
can leverage our institutional strength to
provide something unique to patients that
they couldn’t get somewhere else.”
Planning for the Future

The launch of the new women and children’s
service line is just the beginning. In the
future, tools like single medical records
maintained across lifetimes could support
continuity of care for pediatric patients
entering the adult medical arena. Combined
pediatric and adult centers of excellence,
with partner institutions sharing space and
other resources, could be positioned to
provide the next generation of patient care.
Today, Nemours and Jefferson enjoy a
collaborative partnership in their transplant
departments, which sets the stage for other
opportunities. “We see all sorts of possible
connections between Nemours and Jefferson,
and with a little bit of effort, we can make
both institutions stronger,” says Greenspan.
“For example, Nemours is a leader in pediatric
orthopaedics, and Jefferson is a leader in
orthopaedics, so if Jefferson has a pediatric
patient with an orthopaedic problem, we
should automatically refer him to Nemours
rather than another children’s hospital in
Philadelphia. Together, we can be number
one in orthopaedics.”
Like most pediatric departments across
the United States, transitioning pediatric
patients to adult medical care is a critical
issue for Nemours. “Children with chronic
health conditions can find progressing to

adult medical care very difficult after being
cared for by a children’s hospital for most of
their lives,” says Corso. “So our partnership
with Jefferson positions us well to help
make this transition smoother for patients
and families.”
Learning to seamlessly transition
pediatric patients to Jefferson will benefit
the hospitals and patients alike. By taking
advantage of connections in every specialty,
from family practice to cardiac disease, adult
care could be handled by a Jefferson provider.
“This is important for our patients but also
for Jefferson’s longevity, because that’s
where many of our patients are going to
come from in the future,” says Greenspan.
Children with chronic disease make
up one of the most challenging patient
populations to hit the triple targets of
improving quality, enhancing access and
reducing costs because they struggle with
their conditions for a very long time. In the
past, they wouldn’t have survived into
adulthood. “Jefferson is uniquely positioned
to manage them efficiently, and as we do
that, we will improve the bottom line of our
business,” says Greenspan. “If we leverage it
properly, we can be the medical home for
kids with complex disease throughout the
world because partnerships between pediatrics and adult institutions are rare.”
In addition to partnering on pediatric
training and clinical care, there is an
expanding research relationship that spans
basic lab work and clinical studies at both
institutions. Jefferson professors, associate
professors and assistant professors at all
levels are working in labs, in the clinical
arena and in the outpatient area of
Nemours. One reason that research has
been growing steadily since 2000 is that
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Pediatrics residents Matt Demczko, MD ’12, and
Tracy Hills, DO, with a young patient at Nemours.
Photo by Brad Gellman, courtesy of Nemours/
Alfred I. duPont Hospital for Children.

Jefferson investigators who want pediatrics
to be part of a study’s population will
reach out to Nemours.
A Business Case to Partner

As hospitals across the country wrestle with
pressure to increase efficiency, healthcare
partnerships are on the upswing, according
to a March 2012 report by Moody’s Investors
Service Inc. While hospitals have always
looked to mergers as a way of becoming
larger, some hospitals will join forces with
once-unlikely partners — health insurers
and for-profit companies — the report says.

Academic medical centers are not immune
to these challenges, and strategic partnering
is quickly becoming a key component of
long-term planning.
“We don’t have the luxury of thinking in
monolithic, self-focused ways, like we did
30 years ago,” says Schlaff. “Frankly, unless
it’s illegal or unethical, we can entertain
any discussion.”
One suggestion is to remake the relationship between center city academic medical
centers and community-based teaching
hospitals. “We need a hub and spoke model,
where the quaternary care academic center

is the hub and strong relationships with
community-based teaching hospitals go out
like spokes on a wheel,” says David Paskin,
MD ’64, vice dean for graduate medical
education and affiliations. “That way you
can have patient care delivered at the
academic center or the community-based
teaching hospital while maintaining access
to the academic medical center if requested.
Our neuroscience network is an example of
how this can work successfully. There is no
sense economically with everyone having
expensive technology and expertise in
everything at every moment everywhere.
The role of an academic center like Jefferson
should be to provide those kinds of services
and fortify the relationships that we have
with the affiliates.”
Greenspan agrees. “In the future, complex,
challenging cases that other hospitals don’t
want to deal with are going to come to a
major academic hospital. A large segment
of that could be young adults with special
healthcare needs that have weathered the
storms of the children’s hospital but are
now looking for medical homes in the adult
arena. There could be a business case made
for tracking complex patients because we
do it better, we do it cheaper and we do it
with better access,” he says.
“If we take care of these mothers and
these children, if we do this well and build
new programs, it will be good for Jefferson
and will have positive financial implications.
We can articulate a vision that’s unique to
us,” says Schlaff. “We can do it.”
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Residency Program Limits:

Can We Break the
Training Bottleneck?
By Karen L. Brooks

For fourth-year medical students, “March Madness” has
nothing to do with basketball. They spend the first three
weeks of the month anxiously awaiting Match Day, when
they will unseal the envelopes that hold their fates.
The Match process, coordinated by the
National Resident Matching Program
annually since 1952, involves a computer
algorithm that synchronizes applicants’
preferences with those of residency
program directors to fill training slots
across the country.
Although March 2012 brought the
highest Match rate in 30 years — 95 percent
of fourth-year allopathic students received
residency placements — the future of graduate medical education in the United States

Story Summary
Medical school enrollment is growing
steadily, but the number of available
residency slots is not.
Concerns abound about new graduates’
ability to complete their training as
well as the nation’s ability to meet the
healthcare needs of a growing and
aging population.
Federal support for graduate medical
education has been frozen since 1997;
physicians and some legislators are
lobbying for increased funding.

remains in limbo. The number of first-year
residency applicants has swelled by more
than 6,500 since 2001, but the number of
positions available has not kept pace,
increasing by a mere 3,000 over the
same period.
A freeze in federal support for GME has
stifled the growth of residency opportunities,
worrying healthcare experts who say
America no longer has the capacity to train
enough physicians to meet the public’s
needs. Aging baby boomers, skyrocketing
rates of chronic disease and the barrage
of 30 million newly insured individuals
under the Affordable Care Act will apply
mounting pressure to an already overstretched system.
“U.S. medical schools have been
expanding enrollment and are on track to
increase capacity by 30 percent by 2016,”
says Darrell G. Kirch, MD, president and
CEO of the Association of American
Medical Colleges. “But without an increase
in federal support to create more residency
slots, we will not be able to avert the
expected shortage of 90,000 physicians
by 2020.”

Competition Up, Funding Down

In 2012, 815 fourth-year medical students
failed to match, and that figure will grow in
coming years, according to Thomas J. Nasca,
MD ’75, CEO of the Accreditation Council for
Graduate Medical Education, an organization
that accredits GME programs.
“We will not have nearly enough entrylevel residency positions for the combined
graduating group of allopathic and
osteopathic physicians by 2020 if current
enrollment trends continue,” says Nasca,
former dean of JMC. “The problem is not
just that we won’t be able to meet the
training needs of young physicians but that
we won’t be able to meet the healthcare
needs of the general public.”
The enrollment trends Nasca references
involve schools’ responses to the AAMC’s
projection of a shortage of 45,000 primary
care physicians and 46,000 surgeons and
specialists by 2020. Colleges and universities are steadily expanding class sizes to
meet the demand for more physicians, and
there are currently 18 new U.S. medical
schools under development.
Regardless of the spike in enrollment,
the number of federally funded residency
training positions has remained frozen
since the Balanced Budget Act of 1997.
Federal, state and private funds all
contribute to GME, but Medicare covers
the bulk — about $9.5 billion per year to
support the salaries of residents and
supervising physicians as well as to subsidize
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at JMC, says these cuts could lead to a
national crisis.
“What’s the point of graduating students
with significant educational debt who can’t
go on to complete their training and become
physicians? This is a huge challenge for
American health care, as it only increases
the competition for the current residency
spots without increasing the supply of
practicing physicians — in the future, we’re
not going to be able to meet workforce
needs,” Pohl says.
As millions of people gain insurance for
the first time, a shortage of primary care
physicians poses the most significant workforce concern. Nasca says academic health
centers will have to “get creative” if GME
funding decreases.
“Institutions can expand internal
medicine, pediatrics and family medicine
residency programs by ceasing to pay
residents in more competitive programs
like dermatology, orthopaedic surgery and
radiology. They could use federal funds
that previously supported the competitive
programs to pay for new primary care
positions and could start charging residents
in the more competitive programs tuition,”
Nasca says.
“We could also see residencies become
funded by device manufacturers or pharmaceutical companies,” he says. “And the
conflict of interest issues and influence on
the physician’s future practice in that case
would be disastrous.”
A Push for Change
Joseph Majdan, MD, congratulates a
student at Jefferson Match Day 2012.

additional costs associated with running a
training program, such as more patient
testing. Recently, there have been multiple
proposals to slash GME funding as
Congress looks to cut federal spending; the
Medicare Payment Advisory Commission
and the National Commission on Fiscal
Responsibility and Reform have recommended reductions as high as 50 percent.
Charles Pohl, MD ’87, senior associate
dean for student affairs and career counseling

The Accreditation Council for Graduate
Medical Education estimated in a 2011
report that a 50 percent reduction in
Medicare GME funding would force the
closure of 2,551 residency and fellowship
programs and the loss of 33,023 GME
positions across the country — results that
would devastate young trainees as well
as teaching hospitals, which depend on
residents to provide patient care at a lower
cost than attending physicians.

Ibukun Akinboyo and Victoria Rose,
both of the JMC Class of 2012,
celebrate their Match results.

With projected physician shortages in
mind, legislators have drafted bills that aim
to lift the 1997 GME funding cap. The
Resident Physician Shortage Reduction and
Graduate Medical Education
Accountability and Transparency Act, or
HR 6352 — which was introduced in the
House Aug. 2, 2012, and has a companion
bill in the Senate — calls for Medicare to
fund 15,000 new residency positions over
the next five years. Another bill, HR 3667,
proposes a Medicare-funded primary
care residency pilot project in communitybased clinics and hospitals to fill healthcare
gaps in rural and other underserved
communities.
Federal budget woes are likely to interfere
with the system’s growth, though, and
expanding GME programs is expensive.
Nasca says the cost would be worth it.
“Residencies aren’t just about training —
they are also about patient care. Think about
the fact that there are 125,000 physicians in
training right now, which is one of out
every six practicing physicians. Residents
provide an enormous amount of care, yet
they account for less than 2 percent of the
Medicare patient care spending budget,” he
says. “Purely based on the amount of care
that residents deliver, there should be more
federal funding for GME.”
The Institute of Medicine, the health arm
of the National Academy of Sciences,
is also investigating GME issues. An
18-member committee has been appointed
to analyze the entire GME system, from
regulation to financing to governance. The
group will release its recommendations for
improving GME by spring 2014.
“I am hopeful that the IOM committee
will move beyond funding to talk about
workforce needs and specialty distribution
and that they will emphasize the need to
better structure educational programs to
meet the needs of the public,” Nasca says.
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SOAP Cleans up the Scramble
Before 2012, students who failed to
obtain a residency during the initial match
resorted to a process called the “scramble.”
On Monday of Match Week, students
who learned they did not match could
meet with their advisers to form a game
plan for Tuesday, when a list of programs
with available first-year positions was
published. Tuesday at noon, they could
start contacting unfulfilled programs with
hopes of securing a slot.
The scramble was chaotic and highly
competitive — phone and fax lines would
become clogged, and positions were
filled quickly and often haphazardly. To
streamline the process, last year the NRMP
introduced the Supplemental Offer and
Acceptance Program (SOAP). Unmatched
applicants now receive a list of unfilled
positions on Monday and can begin
applying right away, but they cannot
reach out to the program directors
themselves. Instead, the programs began
extending offers in eight rounds that start
on Wednesday. Applicants have two
hours to make a decision after receiving
an offer.
“The NMRP introduced SOAP to allow
more time for communication between

students and programs during Match
Week. But like any new process, it
presented some challenges,” Charles
Pohl, MD ’87, says. “The student affairs
team was often removed from the
equation — during the scramble, we
were very present to advise our students
about programs and career choices that
matched their needs and to advocate for
our stronger students to residency
programs. But during SOAP, students
were alone in the driver’s seat.”
Pohl says some students found that
programs pressured them to commit
immediately after receiving an offer
regardless of the allotted two-hour
window to ensure that their program
filled the open position.
“Programs didn’t want to remain
unmatched any longer than they had to
and sometimes pushed students to rush
an acceptance, which was uncomfortable
and unfair. This was not an outcome
intended by the NRMP, though, and over
time I do expect some of these kinks with
SOAP to be worked out,” he says.

Illustration by Chris DePietro
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Whooping Cough’s
Comeback and Consequences
By Karen L. Brooks

{

In 2012, people across the United States suffered more
than 1 billion common colds — and chances are, you
endured at least one of them. But how did you know
it was just a cold and not a case of whooping cough?

}
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Story Summary
	A recent resurgence of whooping
cough has alarmed healthcare experts.
	Weaker vaccines and fear of
vaccinations have contributed
to the spike in cases.
	Pediatricians and other physicians
need to educate their patients on
the importance of vaccination.

S

cientists introduced a vaccine
against whooping cough, or
pertussis, more than 70 years ago,
but recent surges show the illness is
far from eradicated. Last year brought
the worst outbreak the nation has seen
since 1959, with more than 39,000 cases
reported to the Centers for Disease
Control and Prevention — more than
twice the number reported in 2011. And
experts know that many more cases
went unrecognized.
“You really have to be looking for
whooping cough to diagnose it in adults,
since they often experience mild symptoms,” says Cynthia Hill, MD ’87, a
pediatrician with Society Hill Pediatrics
in Philadelphia. “The danger begins
when these adults have contact with
infants, because for them, whooping
cough can be fatal.”
Whooping cough initially feels like a
regular cold, but within weeks a violent
and uncontrollable cough develops,
lingering for up to three months. The
highly contagious illness gets its name
from the “whooping” sound made by
those infected as they try to inhale
during these bouts of coughing.
In infants lacking antibody protection,
coughing spells can be so harsh that
eating, sleeping and breathing can
become nearly impossible. Those who
are not fully immunized may develop

pneumonia or seizures, and more than half
of babies who contract the illness must be
hospitalized. Eighteen Americans, most of
them infants, died from whooping cough
in 2012.
Gary A. Emmett, MD ’76, says most of
these deaths could have been prevented.
“Whooping cough naturally follows a
three- to five-year cycle, but there are
other reasons we are seeing an increase,”
says Emmett, a pediatrician with Nemours
and director of hospital pediatrics at
Jefferson. “Unfortunately, most of those
reasons involve human error or unjustified
fear that can lead to very sick children.”

Why Cases Are Climbing
Whooping cough’s spike can be partially
explained by an anti-vaccination movement that has led many parents to
decline immunizations for their children.
In recent years, widespread statements in
the media — including some from highprofile celebrities — have linked vaccines
to terrible health problems, causing panic
among the general public.
Although these claims have no scientific basis, more and more families are
forgoing vaccinations and contributing to
outbreaks in the process. All U.S. states
allow religious and medical exemptions
for children’s vaccinations, but half of
the whooping cough cases in 2012 came
from six states that offer a personal or
philosophical exemption, according to
the CDC.
“People believe what they see on television and the Internet over what they
hear at the doctor’s office. So many
people think you get sick from vaccines,
but that’s not true,” Emmett says. “Those
refusing vaccines have not seen a lot of
disease or had personal experience with
it, so they don’t realize how important
vaccinations are. As we see more acute
illness, they could get a rude awakening.”

And even people who support vaccination can fall victim to whooping
cough. A reformulated vaccine has
proved weaker than its predecessor, and
immunity wanes over time. In 1997,
the original “whole cell” DTwP vaccine
— which protected against diphtheria,
tetanus and pertussis and contained
entire, dead pertussis bacteria — was
phased out because of concerns about
side effects like high fevers and sore
limbs. But the new vaccine, the acellular
DTaP given to infants and children up
to age 7, gradually loses effectiveness,
dropping to about 70 percent protection
within five years.
“The medical community made a
conscious decision to reduce side effects
but ended up inadvertently changing
the long-term immunogenicity of the
vaccine. It’s still a great vaccine — it just
doesn’t give you permanent immunity,
and you need boosters throughout life,”
Emmett says.
But a booster called Tdap for teens and
adults also weakens after a few years, and
many adults don’t even realize they need
it. The CDC reports that just 8 percent of
American adults have received the Tdap
booster since it became available in 2006.
“Many adult patients don’t know
to ask about Tdap, and clinicians who
treat adults aren’t always used to giving
vaccines like pediatricians are,” Emmett
says. “Vaccinating is an expensive
process that requires a lot of staff time.
Not all adult practitioners have those
resources, and if they aren’t giving shots
frequently, it’s hard to keep them around.
They expire, and that costs money.”

Stopping the Spread
Even though the newer vaccine doesn’t
last as long as the old one, experts say
vaccination is still the best way to avoid
whooping cough. Vaccination reduces
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Pediatrician Cynthia Hill, MD ’87, vaccinates a 2-month-old patient. Photo by Sabina Pierce.

“Our biggest push as pediatricians is to immunize
anyone who will be taking care of an infant: parents,
grandparents, siblings, babysitters. When I educate
my patients and their families about the importance
of immunizations, they are more likely to comply.”
– Cynthia Hill, MD ’87

the risk of infection and of passing the
infection along if you do get sick. It also
results in shorter, less severe symptoms.
In an effort to better protect infants,
an advisory panel for the CDC recommended last year that pregnant women
get a pertussis booster shot after their
20th week of pregnancy. This not only
protects mothers but also passes antibodies along to fetuses in the womb for
earlier protection in the first months
of life.
Currently, the DTaP vaccine is administered at ages 2, 4 and 6 months, then
again at 15 to 18 months and finally at
4 to 6 years. A booster is recommended
at 11 or 12, but studies are examining
whether it should be given earlier than
that, perhaps at 8 or 9, to better protect
children in their preteens.
The Food and Drug Administration
has approved the Tdap booster as a onetime injection for adults through age
64 in lieu of a regular tetanus shot, but
physicians expect guidelines to change
soon to call for repeated boosters every
decade.
“Our biggest push as pediatricians is
to immunize anyone who will be taking
care of an infant: parents, grandparents,
siblings, babysitters. When I educate
my patients and their families about the
importance of immunizations, they are
more likely to comply,” Hill says.
Emmett agrees that education is essential. “There is no way to make everyone
get vaccinated. But what people need to
realize is that vaccines aren’t for individuals — they’re for society. When you opt
out of getting a vaccine for your child,
you endanger not just your child, but all
children,” he says. “People need to feel
more of a group identity rather than only
taking responsibility for themselves.”
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Jefferson Faculty
Robert L. Brent, MD, PhD:

An International Authority on Congenital Disorders
Bob Brent can’t explain what drew him to the field of medicine.
Nobody in his family had attended college, let alone medical school,
and he didn’t have any physician role models as a child. But even in
his youth, he somehow sensed his calling.
“When I was 8, I decided that I was going to be a physician who
didn’t charge his patients,” he says. “My mother didn’t think that
sounded very practical.”
Brent wasn’t deterred and went on to fulfill his dream. One of
the world’s leading experts in radiation biology, developmental
biology, embryology and teratology, he has been providing free
reproductive risk assessments to women and families for more
than 50 years.
Raised in Rochester, N.Y., Brent didn’t hesitate before pursuing
his ambitions. Knowing he would be drafted into World War
II after high school, he took his advanced exams early and was
accepted to the University of Rochester at age 15. As a student, he
held a job with the Manhattan Project (later the Atomic Energy
Commission), researching the effects of radiation on developing
embryos. This work provided the foundation for his entire career.
The war ended before the date of Brent’s U.S. Army induction
notice, so he completed his bachelor’s degree at just 18. “Getting
into medical school as a teenager wasn’t easy. I applied to 86
schools over the next three years,” says Brent, who continued his
radiation research the whole time.
Finally accepted to the University of Rochester School of
Medicine and Dentistry at 21, Brent received his MD in 1953 and
a PhD in embryology and radiation biology in 1955 and did a
pediatric residency at Massachusetts General Hospital. He then
served two years in the Army, heading the radiation biology
section at the Walter Reed Army Institute of Research, where he
was involved in monitoring radiation exposure resulting from
nuclear bomb testing programs.
After his military service, Brent joined Jefferson’s faculty
and advanced to become chair of pediatrics, a role he held for
three decades. He is now the Distinguished Louis and Bess Stein
Professor of Pediatrics, Radiology and Pathology and head of the
Clinical and Environmental Teratology Laboratory at the Alfred
I. duPont Hospital for Children in Wilmington, Del. — a major

Jefferson partner. The author of nearly 500 scientific publications,
including six books and four movies, Brent has won many awards
for his achievements, such as Castle-Connolly Physician of the
Year; the Alfred I. duPont Award for Excellence in Children’s
Health Care; and election to the Institute of Medicine of the
National Academies.
Although he rarely works in the clinic these days, Brent
continues to counsel patients as an expert editor for the online
community of the Health Physics Society, a group of specialists
in radiation safety. As leader of the site’s pregnancy section, he
conducts about 2,000 free consultations per year for pregnant
women and families who have been exposed to potentially toxic
agents. He recently surpassed his 25,000th assessment.
Brent’s charitable activities extend beyond free health
counseling. He and his wife of 63 years, Lillian, have established
four scholarships at Jefferson and in 2011 created the Robert and
Lillian Brent Alumni Giving Incentive Fund to inspire generosity
among JMC graduates. The Brents made a donation that places funds
in each new graduate’s account for five years, resulting in 100 percent
giving participation for that class. They hope that after five years,
alumni will be motivated to maintain this status on their own.
“The gratification and joy of sustaining an institution of education is a very rewarding part of life,” Brent says.
And while Brent might not have encountered many physician
role models growing up, he has certainly served as one for
subsequent generations. His sons, David and Larry, are JMC
alumni, and his daughter, Deborah, graduated from the Jefferson
School of Nursing. This past fall, his granddaughter, Elyssa, began
her first year at JMC.
Brent recently shared reflections on his profession.
Q: What brought you to Jefferson back in 1957?
A:	After I was discharged from the Army, I received four job
offers, but Jefferson’s was exceptional. The University offered
me four laboratories, my own animal facility and the rank of
associate professor, even though I was only 29 years old. Also,
the chairman of obstetrics and gynecology, Dr. Thaddeus
Montgomery, interviewed me and was a real class act, just such
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Photo by Cynthia Brodoway, courtesy of
Nemours/Alfred I. duPont Hospital for Children.

an impressive and ethical person. I thought that if this was the
kind of faculty that Jefferson employed, it had to be a good place.
Q:	You’ve enjoyed a lengthy career. What advice would you give
students going into medicine today?
A:	Don’t be discouraged by the pressures and responsibilities that
come with being a physician — they are all worthwhile. No
other profession will give you more satisfaction or allow you to
make a greater contribution to the world. You will constantly
be stimulated by new discoveries, so take every opportunity to
learn. I am 85 years old and still learn at least five things every day.
Q:	Have you ever considered retiring?
A:	No, because I always look forward to going to work and because
I am still helping patients through my Web consultations.
Women who believe that they have been exposed to toxic agents
reach out for a second opinion after their physicians may have
recommend interrupting a wanted pregnancy. I never tell a
patient what to do — I explain risks and let them make their
own decisions. Sometimes, their exposure was so low that
drastic measures aren’t necessary, and I help them understand
that and save lives in the process.

Q:	What inspired you to establish scholarship funds at Jefferson?
A:	I believe that education should be free. Tuition these days is
just too high for a young person to handle. There is nothing
more important than education, and my family wants to make
medical education attainable.
Q:	What is your proudest professional accomplishment?
A:	First, the growth I oversaw in Jefferson’s Department of
Pediatrics. When I became acting chairman, I had three
faculty members and a very small budget. By the time I became
emeritus chairman 30 years later, our main pediatrics site had
moved to the Nemours/duPont Hospital for Children with
140 faculty members and a budget of about $125 million. The
Nemours programs are now among the largest in the country
and a great source of pride for me.
Second, my research. I couldn’t counsel my patients without
having completed so much basic research in reproductive biology,
embryology and toxicology. People I have met or taught over the
years might someday forget me, but my research publications
will live on forever. The medical literature chronicling all of the
new knowledge I uncovered — that is my legacy.
— Karen L. Brooks
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Bar-Ad

Voichita Bar-Ad, MD, associate professor in
the Department of Radiation Oncology, has
been named director of the department’s residency program. Bar-Ad primarily treats head
and neck and gastrointestinal cancer cases
and maintains a research focus on treatmentrelated side effects and toxicities, patient
quality of life and symptom management.

Waldman Receives NCI Grant

Scott Waldman, MD, PhD, chairman of
the Department of Pharmacology and
Experimental Therapeutics, has been
awarded a prestigious “Provocative Questions”
grant from the National Cancer Institute as
part of its program to tackle “important but
not obvious” questions related to cancer.
Out of 700 applicants nationwide, just 57
recipients were chosen.

Knudsen

Headlines

People
Bar-Ad Named Residency
Program Director

Waldman

Waldman’s four-year, $1.2 million grant
will support his studies into the relationship
between obesity and cancer. He is specifically
looking at a hormone receptor known as
guanylyl cyclase C (GCC), found mostly in
the intestinal tract, and how its levels affect
cancer risk.

Knudsen Named Journal Editor

Karen E. Knudsen, PhD, professor of cancer
biology, urology and radiation oncology and
deputy director for basic science the Kimmel
Cancer Center, has been named editor-inchief of Molecular Cancer Research, one
of the American Association for Cancer
Research’s seven major peer-reviewed journals.
Molecular Cancer Research publishes
original, novel and well-designed studies
on the molecular and cellular aspects of
cancer biology. Knudsen began her term
in January 2013.

On the Boardwalk –
with the Clintons
This past June, Jeffrey Joseph, DO,
director of research in the Department
of Anesthesiology, had a chance
encounter with former President Bill
Clinton and Secretary of State Hillary
Clinton on the boardwalk in Ventnor,
N.J. Pictured with Hillary Clinton
are Joseph; his wife, Celia; and his
daughter, Amanda.

Loss of Protein Linked to
Critical Limb Ischemia

Restoring diminished levels of a protein
shown to prevent and reverse heart failure
damage could also help patients with critical
limb ischemia (CLI), researchers from
Jefferson’s Center for Translational Medicine
suggest in a preclinical study published
online Oct. 9, 2012, in Circulation Research.
Low levels of the protein S100A1 have
been linked to congestive heart failure and
high blood pressure and now appear to be
associated with critical lower limb ischemia,
a condition found in type 2 diabetic patients
where blood flow to legs is cut off, often
resulting in amputation. Past studies have
shown that returning the protein to normal
levels or above prevented and/or reversed
congestive heart failure in large animal
models with gene therapy. Given these new
findings, the researchers posit that S100A1
could also be a potential therapeutic target in
CLI to promote revascularization.
The team was led by lead author Patrick
Most, MD, adjunct assistant professor
of medicine, and senior author Karsten
Peppel, PhD, associate professor in the
Center for Translational Medicine.

New Function of ATP Discovered

Jefferson researchers have unraveled a new
function of adenosine triphosphate, or ATP,
beyond its passive roles as an energy source
and a phosphate donor for phosphorylation
reactions. Their studies revealed a new
model of kinase regulation, whereby ATP
modulates an “on-off-switch” mechanism
in Akt — a serine/threonine-specific
protein kinase that plays a key role in
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Most

Peppel

multiple cellular processes such as glucose
metabolism, apoptosis, cell proliferation,
transcription and cell migration — by
inducing conformational changes in the
Akt kinase domain. The three members of
the Akt protein kinase family play key roles
in multiple cellular processes, including
glucose metabolism; cell survival and
proliferation; and cell migration.
A molecular switch that affects the activation state of specific Akt isoforms may be
exploited to modulate Akt signal strength
in malignant diseases, as well as in diabetes
and diseases of the heart and the central
nervous system.
The data was reported in the Proceedings
of the National Academy of Sciences and
was the subject of a perspective in Science
Signaling in its May 2012 issue.

Study Connects Empathy
and Outcomes

Patients of doctors who are more empathic
have better outcomes and fewer complications, according to an empirical study by a
team of Jefferson and Italian researchers who
evaluated relationships between physician
empathy and clinical outcomes among
diabetic patients and physicians in Italy.
The study, published in the September
2012 issue of Academic Medicine, serves
as a follow-up to a smaller Jefferson study
published in the same journal in March 2011.
“This new, large-scale research study has
confirmed that empathic physician-patient
relationships is an important factor in positive outcomes,” said Mohammadreza Hojat,
PhD, research professor in the Department
of Psychiatry and Human Behavior and

Hojat

Halpern

director of the Jefferson Longitudinal Study
of Medical Education in the Center for
Research in Medical Education and Health
Care at JMC. “Compared to our initial
study, it has a much larger number of
patients and physicians, a different tangible
clinical outcome, hospital admission
for acute metabolic complications and a
cross-cultural feature that will allow for
generalization of the findings in different
cultures and different health care systems.”

Contrast-Enhanced Ultrasound
Better Detects Prostate Cancer

Led by principal investigator and Prostate
Diagnostic Center Co-director Ethan
Halpern, MD, researchers have found that
contrast-enhanced ultrasound detects
high-grade prostate cancer better than
conventional methods, making it a more
appropriate approach for screening clinically
important cancers and monitoring low-risk
ones with fewer biopsies. Their phase III
study was published online in September
2012 in the Journal of Urology.
Findings from the randomized, doubleblind trial revealed the technique, which
uses microbubbles to measure change in
blood flow, found almost three times as
many higher-grade cancers using half as
many needle biopsies compared to systematic biopsy methods.

Protein Could Help Guide
Prostate Cancer Treatment

Men who had high levels of the activated
Stat5 protein in their prostate cancer after
a radical prostatectomy were more likely to
have a recurrence or die from the disease

Nevalainen

Buzurovic

compared to men who had little to no
presence of the growth protein, according
to a study published in Human Pathology
by researchers from the Kimmel Cancer
Center at Jefferson. The findings suggest
that Stat5 — which, when activated, signals
cancer cells to grow and survive — could
be an ideal biomarker to help guide patients
and physicians for future treatment.
The team, led by Marja Nevalainen, MD,
PhD, associate professor of cancer biology,
medical oncology and urology, examined
prostate cancer biopsies and tumor tissues
obtained from 562 men who underwent
a radical prostatectomy, comparing Stat5
levels with outcome. They also looked at
prostate tumor tissue in 106 patients who
were under a “watchful waiting” or active
surveillance treatment plan and had no
neoadjuvant therapy.

Tumor Tracking Technique
May Improve Lung Cancer
Patient Outcomes

Medical physicists at Jefferson and the
Kimmel Cancer Center have discovered a
tumor-tracking technique that delivers higher
levels of radiation to moving tumors while
sparing healthy tissue in lung cancer patients.
Researchers have been searching for
ways to better track tumors — which are
in constant motion because of breathing —
in order to up the dosage during radiation
therapy without increasing side effects.
They have now shown that their real-time
tracking technique can achieve such tasks.
The results of the study, which was led by
Ivan Buzurovic, PhD, a medical physics
resident and researcher in the Department
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Medical Frontiers
of Radiation Oncology, and Yan Yu, PhD,
vice chair and director of medical physics,
were published in the November 2012 issue
of Medical Physics.

Brazilian Mediums Shed Light on
Brain Activity During Trance State

A study by researchers at Jefferson and the
University of Sao Paulo in Brazil analyzed
the cerebral blood flow of Brazilian mediums
during the practice of psychography,
described as a form of writing whereby
a deceased person or spirit is believed to
write through the medium’s hand, and
revealed decreased brain activity during
mediumistic dissociative state that generated
complex written content. The mediums
were injected with a radioactive tracer
to capture their brain activity during
normal writing and during the practice
of psychography, which involves the
subject entering a trance-like state. The
subjects were scanned using single photon
emission computed tomography to
highlight the areas of the brain that are
active and inactive during the practice.
“This first-ever neuroscientific evaluation
of mediumistic trance states reveals some
exciting data to improve our understanding
of the mind and its relationship with the
brain. These findings deserve further
investigation both in terms of replication
and explanatory hypotheses,” says Andrew
Newberg, MD, director of research at the
Jefferson-Myrna Brind Center of Integrative
Medicine. The findings appeared in the
Nov. 16, 2012, edition of the online
journal PLOS ONE.

Older Age Marker Needed for
Papillary Thyroid Cancer Prognosis

Jefferson researchers have shown that age
45 is no longer a useful outcome predictor
in the staging of papillary thyroid cancer
patients. Since the 1970s, physicians have
used age at diagnosis to determine the
severity of these cancers. Papillary thyroid
cancers — those including affected lymph
nodes — diagnosed before age 45 are
designated as Stage 1, while the same
cancers with lymph node involvement
presenting after age 45 years are Stage 3.
The team analyzed 45,390 thyroid cancer
cases diagnosed between 2001 and 2007 and
reviewed five-year survival rates. The most
significant drop was seen in those aged 65
to 74 years, though prognosis was still good
at 92 percent.
“With time, we have developed new
therapies and surgical techniques, leading to
better survival rates,” says Jeffrey L. Miller,
MD, co-director of the Thyroid Center at
Jefferson. “We feel that age 45 is no longer
an appropriate age designation to influence
papillary thyroid cancer prognosis.”

NIH Grant to Fund Skin
Disease Study

Researchers at the Jefferson Institute of
Molecular Medicine have been awarded
almost $384,000 by the National Institutes
of Health to investigate the mechanisms
involved in the development of a serious
and sometimes fatal disease, nephrogenic
systemic fibrosis, which is a rare skin
disorder linked to gadolinium-based
contrast agents used in magnetic
resonance (MRI and MRA) studies.

The team, led by Sergio A. Jimenez,
MD, co-director of the Jefferson Institute
of Molecular Medicine and director of the
Jefferson Scleroderma Center, aims to gain
a better understanding of the molecular
mechanisms behind the initiation of the
disorder in order to develop possible new
treatments. They will investigate the role
of specialized cells known as macrophages
and their cell surface receptors known as
Toll-like receptors in gadolinium-based
contrast agent induced skin fibrosis.

Combining Therapies Cuts
Angioplasty, Stenting Complications

Jefferson researchers have shown that
combining distal protection devices with
prophylactic use of the drug nicardipine is
more effective at preventing life-threatening
complications following a percutaneous
coronary intervention such as angioplasty
or stenting on patients who have undergone previous bypass surgery than distal
protection devices alone.
Angioplasty or stenting on bypass
vessels is associated with a high risk of
complications due to distal embolization,
the dislodging of plaque and clots downstream, impairing blood flow and leaving
patients at risk for a heart attack. Distal
protection devices are commonly used to
prevent blockages by catching the dislodged
plaque and clot in a basket-like device,
allowing blood to filter through the
bypassed artery. Still, complications
remain in up to 10 percent of patients.
Preliminary studies have suggested that
prophylactic doses of nicardipine, a
common intracoronary vasodilator, can
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Pictured (from left) are TJU President Richard Gozon; gala honoree William Keane, MD, and his wife, Louise; gala honoree Robert Nicoletti; and TJUH
President David McQuaid, FACHE.

10th Annual Jefferson Awards Gala
Jefferson hosted its sold-out 10th Annual Awards Gala Oct. 25
at the Hyatt at the Bellevue in Philadelphia. Every year, this event
honors two members of the Jefferson community whose leadership has profoundly affected the field of medicine.
Honorees for 2012 were William Keane, MD, the Herbert Kean
Professor and Chair of the Department of Otolaryngology-Head
and Neck Surgery and medical director of Jefferson University
Physicians; and Robert Nicoletti, a local business leader and
philanthropist whose family has established two endowed
professorships at Jefferson.

also help in this regard, but never have
the two techniques been combined.
“Through the combined power of these
two therapies, we have a new approach
that is improving outcomes for this high
risk subset of patients,” says Michael P.
Savage, MD, director of Jefferson’s Cardiac
Catheterization Lab.

Deviating from Radiation
Protocols Increases Risks

Ensuring that radiation therapy protocols
are followed not only decreases deviations
but can improve overall survival in cancer
patients, Jefferson researchers suggested
in a first-of-its kind study presented at the
American Society for Radiation Oncology
54th Annual Meeting in October 2012.
Faculty from the Department of Radiation
Oncology analyzed radiation therapy

The 2012 gala raised more than $700,000 to support two
initiatives selected by the awardees. Gifts honoring Keane will
benefit an education legacy fund supporting otolaryngology
resident training programs, and gifts honoring Nicoletti will
provide scholarship funding for Jefferson Medical College
students in need of financial assistance.
The Jefferson community is grateful to all who helped to
make this year’s gala a resounding success.

protocols, quality assurance measures and
patient outcomes in eight large clinical trials
to determine if deviations were associated
with inferior clinical outcomes. Examples
of radiation therapy deviation include
inadequate targeting of high-risk lymph
node regions or incorrect dose calculation.
Their findings revealed that deviating from
protocols was associated with up to a 75
percent increased risk of treatment failure and
mortality. This suggests that implementing
quality assurance measures to ensure
protocols are followed could improve
outcomes for cancer patients, according
to the authors.

Aspirin as Successful as
Warfarin in Preventing Clots

If you’ve had joint replacement surgery,
you’ve likely been given warfarin, a

common blood thinner and clot-preventer,
prior to surgery. Researchers from the
Rothman Institute at Jefferson have
shown aspirin to be just as effective in
preventing clots — specifically pulmonary
emboli, life-threatening blood clots that
can develop in the arteries of the lungs
following joint replacement surgery. Their
research was recognized as one of the
best poster presentations at the recent
American Association of Hip and Knee
Surgeons meeting in Dallas.
“While warfarin is successful in the
prophylactic prevention of clots it can also
lead to increased bleeding, infections and
hospital readmissions,” says Javad Parvizi,
MD, director of research at the Rothman
Institute and lead author of the study.
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Alumna Profile
Cynthia L. Sears, MD ’77:

A Life’s Work Inspired by Service Overseas
In spring 1979, Cynthia Sears found herself
in a Cambodian refugee camp triaging
35 vomiting, dehydrated children. The
patients, all from a camp orphanage, had
been fed contaminated food, and with the
help of two nurses, it was up to Sears to
care for them — not to mention the dozens
of other refugees with infectious diseases
occupying her residency group’s makeshift emergency ward. “It was experiences
like that that made me realize I wanted to
pursue a career in infectious diseases over
GI medicine,” she says.
Growing up in Pottstown, Pa., Sears
thought she would follow in the footsteps
of her mother and become a nurse. But
her father encouraged her to dream bigger
and become a doctor. So as a junior in
high school, Sears applied for the five-year
joint undergraduate and medical degree
program through Penn State and JMC. She
interviewed for the program her senior
year, was accepted, and went off to Happy
Valley and eventually, Philadelphia.
But toward the end of her internal
medicine residency and fellowship at Cornell
Medical Center (now Weill), Sears remained
undecided if she should apply for a fellowship
in infectious disease or GI medicine. Around
the same time, her residency group was
given the opportunity by the International
Rescue Committee to run an emergency
room in a Cambodian refugee camp. So she
went to the camp in Thailand.
“I saw an astonishing array of infectious
disease, including diarrheal illnesses and
childhood illnesses,” says Sears. “Because of
the policies of Pol Pot, there was limited

immunity to common childhood illnesses
built up in the population. When the
refugees were crowded in the camp, there
were outbreaks of childhood diseases and
more — measles, mumps, rubella, chicken
pox, meningitis and cholera. I was in the
middle of it.”
She came back to the United States and
completed one year of the internal medicine
fellowship at Cornell, then applied for
infectious disease fellowships. While waiting
for acceptance, Sears went to Memorial SloanKettering to study with Donald Armstrong,
MD, her attending at the refugee camp and
head of infectious diseases at Sloan-Kettering.
At that point, it was 1981, and HIV had hit
New York City. “That was an amazing year,”
she recalls. “I had a remarkable experience
watching this epidemic unfold and manifest
as opportunistic infections.”
After her year at Sloan-Kettering, Sears
completed her infectious disease fellowship
at the University of Virginia. By then, she
had decided to train to become an enteric
pathogen expert — a process she says
is ongoing.
Having worked at Johns Hopkins
University School of Medicine for the past
25 years, Sears, a professor of medicine in
infectious diseases and gastroenterology,
is now studying a bacterium called enterotoxigenic Bacteroides fragilis (ETBF). She
was originally examining how toxins made
by bacteria might contribute to diarrheal
disease. But in working with ETBF, her
team learned that it linked to an oncologic
pathway. They tested the hypothesis that
ETBF may induce tumors in the colon,

and those experiments proved positive. “In
research you end up with a few moments,
a few experiments, over the course of your
career that really make you rock back on
your heels and think more deeply,” she says.
This was one of them.
Now her team is working to understand
the mechanisms that cause bacteria to
be oncogenic in the colon and how the
microbiome contributes to the pathogenesis
of colon cancer — a task that will be her life’s
work. “I’ve considered taking on a leadership
position, but I think I am going to work
away at this question of how bacteria may
influence colon cancer,” she says. “I hope we
can come up with a new approach to prevent
a disease that is extremely common.”
In her spare time, Sears is involved
with Moveable Feast, a Baltimore-based
nonprofit with a mission to provide
nutritious food at no cost to low-income
individuals with life-threatening diseases,
particularly HIV and cancer. Besides sitting
on the board of directors of Moveable Feast
and volunteering to deliver food, Sears
participates in Fierce Chicks Rock, a bike
team that completes an annual 140-mile
ride called Ride for the Feast to raise funds
for Moveable Feast.
But whether she’s working with Moveable
Feast or in the lab at Hopkins, Sears
remembers the refugee camp and the career
clarity it provided her. “There are times when
I realize I am really enjoying my job because
aspects remind me of the refugee camp,” she
says. “Those five months made a big impact.”
— Elizabeth Seasholtz
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ClassNotes
’47

Joseph Corson is a surgical
pathologist currently focusing on
malignant mesothelioma. He is a
professor of pathology at Harvard
Medical School and lives in
Lexington, Mass.

’53

Thurman Gillespy Jr. is founder
and senior partner of the
Orthopaedic Clinic of Daytona
Beach, Fla., a nine-physician
orthopaedic group that includes
his two sons, Albert, MD ’82, and
Mark, MD ’86, as well as Gilbert
Martin, MD ’54. Gillespy stopped
performing surgeries four years
ago but still sees office patients
part time and serves on several
committees at the area hospital.

’57

Vincent Cuddy retired from
practicing surgery in 1996. He
is a volunteer faculty member
in the University of Pittsburgh’s
Department of Surgery and
Anatomy. Cuddy has 18 grandchildren and lives in Beaver Falls, Pa.
Abram Hostetter retired from
psychiatry practice in 2003 and
lives in a retirement community in
Charlottesville, Va. He enjoys taking
care of his son’s three-acre lawn
and garden and is still involved in
a genetic research project.

’61

Jerry Harrell recently reconnected
with Ed Downing, MD ’64, at a
medical mission seminar and reminisced about work in Mombasa,
Kenya. Downing and his wife, Lois,
are dear friends of Harrell, who
lives in St. Simons Island, Ga.

’62

Harry Candela retired in 1994
after 30 years with the U.S.
Navy. He now volunteers with
the Nemours program “Healthy
Habits for Life,” a childhood
obesity prevention initiative, in
Orlando, Fla. Candela lives in
Maitland, Fla.

William Harrer, Courtney
Malcarney, Joseph Sokolowski
and Stephen Vasso joined together
to organize a private celebration
during their 50th reunion weekend
in October. Malcarney and his wife,
Kay, provided their home; Vasso
and his wife, Edna, provided the
wine; and Harrer and Sokolowski’s
wives, Carol and Maureen,
provided the food. The classmates
would like to express thanks to
their peers for their participation
in reunion weekend and to Phillip
Marone, MD ’57, MS ’07, and
Toni Agnes of the alumni relations
office at JMC and everyone at the
Jefferson Foundation for their help
with this year’s reunion events.

’64

John P. Whitecar writes that he
is proud of his two daughters,
Linnane R. Batzel, MD ’99, and
Colleen J. Whitecar, MD ’06,
both of whom graduated from
Jefferson. Whitecar continues to
enjoy practicing hematology
and oncology in Columbus, Miss.

’67

Anthony Padula is medical director
for Independence Blue Cross in
Philadelphia, where he lives.
Elliot Rayfield is an endocrinologist
and clinical professor of medicine
at the Mount Sinai School of
Medicine in New York. He serves
as co-chair of the Endocrine
Society’s Sawin Library and
Resource Center.

’70

Peter Pizzutillo has served as
director of orthopaedic surgery
and associate surgeon-in-chief
at St. Christopher’s Hospital for
Children for nearly two decades.
He reports that “the clinical
care, educational and research
activities and mentoring of young
associates at this institution have
provided me with a stimulating
and energizing career.” Pizzutillo
lives in Wynnewood, Pa.

’72

Robert McKay splits his time
between practicing anesthesiology and holistic medicine. He is
currently studying acupuncture,
myofascial release, therapeutic
yoga and reiki. McKay lives in
Bristol, Tenn.

Michael P. Russo reports that he
is semi-retired from an OB/Gyn
practice in York, Pa. He enjoys
traveling with his wife, Barbara,
visiting their sons in Naples, Fla.,
and Erie, Pa.

James Redka practices family
medicine in Williamsport, Pa.
He is a board member for the
Pennsylvania Medical Society
and the Lycoming County Health
Improvement Coalition and is
chairman of the board of the
Susquehanna Community Health
and Dental Center.

Angela E. Lin reports that she
enjoys working as a medical
geneticist at Massachusetts
General Hospital and recently
was promoted to clinical
professor at Harvard Medical
School. Lin has applied her
previous training in pediatric
cardiology to her current work
in cardiovascular genetics
and coordinates the Turner
Syndrome Clinic and Hereditary
Hemorrhagic Telangiectasia
Center. Lin writes that her
highlights from 2012 included
receiving the service award
from the National Birth Defects
Prevention Network; seeing
classmate Marianne T. Ritchie,
MD ’80, named the new JMC
Alumni Association president;
and unexpectedly running into
classmate John C. Wain, MD ’80,
now director of thoracic surgical
research and the surgical director
of MGH’s lung transplant
program, in an elevator at MGH.
After 15 years working in the
same institution, Lin and Wain
promised to do lunch very soon.

William Wixted continues to work
full time at his private urology
practice. He lives in Linwood, N.J.

’75

Joseph J. Korey is still actively
practicing obstetrics and gynecology. He and his wife, Linda, live
in Reading, Pa., and celebrated
their 40th anniversary in June 2012.

’76

David W. Willis recently
returned to the east coast after
30 years in Oregon, having been
recruited to the Health Resources
and Services Administration’s
Maternal Child Health Bureau as
director of the Division of Home
Visiting and Early Childhood
Systems. This work involves
building early childhood investments to address the social
determinants of health, education
and social capacities of our most
vulnerable children. Willis now
lives in Bethesda, Md.

’78

Alexander Mamourian was
recently promoted to full professor
of radiology at the University of
Pennsylvania. He sends his thanks
to the Jefferson faculty who
supported him during his time at
JMC and his best wishes to all of
his classmates. Mamourian lives
in Wayne, Pa.

’80

’81

Stuart Gordon is the division
head for adult hip and knee reconstruction at Cooper University
Hospital in Camden, N.J. He
lives in Haverford, Pa., with his
wife, Marianne Ritchie, MD ’80,
president of the JMC Alumni
Association.

’82

Judd Moul is director of the Duke
Prostate Center and the James H.
Semans, MD, Professor of Surgery
at the Duke University School of
Medicine. He and his wife, Ellen,
live in Chapel Hill, N.C.
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’85

David S. Seres has been promoted
to associate professor of clinical
medicine at the Columbia
University College of Physicians
and Surgeons and Institute of
Human Nutrition. Seres recently
was appointed to the Medical
Advisory Board of Consumer
Reports. He lives in New York City.

’87

Mark D. Falls has a private ophthalmology practice in Vienna, Va., and
is involved with residency training
at Georgetown University Hospital/
Washington Hospital Center.

’97

Christopher Doty recently
accepted a position as vice chair of
education and program director
for the University of Kentucky’s
emergency medicine department.
He and his wife, Laurie, have left
their longtime home in Brooklyn,
N.Y., for a new southern adventure.

’98

Philip C. Ovadia welcomed his
second daughter, Layla Mackenna,
in November 2012. Ovadia practices
cardiothoracic surgery with
Heritage Valley Health System and
lives in Beaver, Pa., with his wife,
Shelly, and 2-year-old daughter, Eva.

’02

Rita M. Pechulis has been appointed
medical director of the medical
intensive care unit at Lehigh Valley
Hospital’s Cedar Crest campus.
She has two children, Emelia and
Samuel, and lives in MacUngie, Pa.

’08

Holly Simpson and Gerard Berry
Jr. were married on June 30, 2012,
at the Pennsylvania Academy of
Fine Arts. The groom’s father,
Gerard Berry Sr., is a JMC graduate
from the Class of 1975.
Laura Snyder is a fifth-year
neurosurgery resident at the
Barrow Neurological Institute at
St. Joseph’s Hospital and Medical
Center in Phoenix, where she lives.

Alumni Association
President’s Message
Let’s talk technology. OK, so I don’t have a
smart phone. No problem. My “dumb phone”
keeps me connected just fine, and it’s still more
convenient than a pay phone.
What’s that? You’re aghast that my 8-yearold Toyota has no GPS? That’s OK. Stopping
for directions at gas stations leads to making
new friends.
As of Oct. 1, 2012, federal regulations
mandate that all medical records be electronic;
we no longer have a choice about documentation.
On the bright side, now we can tap into
universal records with notes from colleagues,
lab and X-ray results and medication lists.
Even better, we can access the information
from the hospital, office or home. Another plus
is not worrying about misplaced charts in a big
office. And no more jokes about doctors’ illegible
handwriting. The printed word is definitely
easier on the eye.
But beware — the new world of Electronic
Medical Records isn’t perfect.
1. Make use of free-texting. The drop-down
selections do not always offer the options I
might want to include when I’m completing
a history and physical. An effective clinician
captures the specific nuances in each patient’s
history and physical. A fill-in-the-blank
template doesn’t always lend itself to communicating the exact details that distinguish the
belly pain of a virus from appendicitis, or
irritable bowel from inflammatory bowel.
2. Look the patient in the eye. Students learn
the value of appreciating the Hippocratic Facies —
the expression on the patient’s face. How can we

win a patient’s trust if our back is turned while we
type on the computer keyboard?
3. Do not depend on spell check. Read your
notes before you click “finalize.” On many
occasions, I have dictated a letter to a referring
doctor. When reviewing the typed draft, I have
found the words “Unfortunately, the biopsies
were negative for cancer,” when in fact I had
recorded the words “Fortunately, the biopsies
were negative for cancer.” This error would go
undetected if I depended on spell check.
4. Read notes critically. The document isn’t
more official or valid just because it’s printed.
Remember, it’s not hard to “click and send” an
error, such as ordering milligrams of a drug
rather than micrograms.
5. Reference “Copied and Pasted and
Misdiagnosed (or Cloned Notes and Blind
Alleys),” a very informative article written
by our Jefferson colleague, Dr. Susan Rattner,
that suggests EMR makes it easy to cut and
paste other clinicians’ notes. “The process of
composing a note encourages critical thinking;
copying a note does not.” Students and residents
need to start from scratch, take their own
histories to learn the process, but also because
the history is dynamic. Symptoms and signs
often change between the time of the initial
exam and later exams. A patient may
remember additional vital information when
repeating the history the third or fourth time.
6. Pick up the phone and call your colleague.
Direct communication with another physician
allows for more accurate exchange of details
and more importantly, the chance to brainstorm
ideas. Such collaboration leads to safer, more
efficient and cost-effective patient care.
So no need to say goodbye to the Flinstones
and leave the stone-age town of Bedrock
for Orbit City. The Jetsons don’t live in
nirvana, either. Live somewhere in between
by embracing the advantages of technology
but sticking to the basics of a conscientious,
methodical, thinking clinician.

Marianne T. Ritchie, MD ’80
President, JMC Alumni Association
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InMemoriam
’44J

Irvin Gerson, 93, of Bala Cynwyd,
Pa., died Oct. 18, 2012. Gerson was
a family practitioner, neurological
researcher and faculty member at
JMC. He is survived by his wife,
Rosalie; five children; and eight
grandchildren.

’44S

Herbert S. Hunter, 94, of
Sacramento, Calif., died Feb. 19,
2012. Hunter had a successful
career as an ear, nose and throat
specialist. He retired from private
practice in 1986, then served in
the U.S. Air Force for three years
as flight surgeon at McClellan Air
Force Base and established the
Hearing Preservation Clinic. He
was preceded in death by his wife
of more than 60 years, Lois.

’46

A. Joseph Cappelletti, 90, of
Pinehurst, N.C., died April 4,
2012. Cappelletti served as class
president at JMC. He was a lieutenant in the U.S. Navy from 1955
to 1957. Throughout his career, he
was affiliated with Waterbury
Hospital in Connecticut, where he
established the first coronary care
unit in the state and served as
chief of medicine and chief of
staff. He survived by his wife of
61 years, Norma, and four sons.
Melvin L. Reitz, 89, of Kutztown,
Pa., died June 15, 2012. He was a
U.S. Army veteran of World War
II and practiced family medicine
in Tower City, Pa., for 35 years.
He is survived by his wife, three
children, five grandchildren and
three great-grandchildren.

Seymour Krevsky, 92, of
Bloomfield, Ill., died July 11,
2012. Krevsky practiced pediatric
medicine for 50 years. He is
survived by his wife, Margery,
and a stepson, Joseph Stearns.

’47

Luther F. Corley Jr., 87, died in
September 2011. Corley practiced
family medicine in Boaz, Ala., for
more than 45 years after serving
in the military in Korea and was
instrumental in the formation of
the Boaz-Albertville Hospital. He
is survived by his wife, Clare; two
sons, Trey, MD ’79, and Tom, MD
’80; and three grandchildren.

’49

Richard Murphy Whittington
died Nov. 20, 2012, in Palm Coast,
Fla. After graduating from JMC
and serving in the U.S. Army in
Korea and at Walter Reed Army
Hospital, Whittington joined the
Veterans Administration in 1952.
He held a number of positions
within VA including chief of staff
at the Cleveland VA Hospital and
associate deputy chief medical
director at VA Headquarters in
Washington. He became chief of
staff at the Gainesville VA Medical
Center in 1976 and served as associate chief of staff for geriatrics
and extended care from 1992 to
1999. After 52 years of government
service, Whittington continued
serving the VA in his retirement
as a consultant in geriatric medicine to the VA network director in
Florida. He was preceded in death
by his first wife, Eileen; his second
wife, Joan; and his son, David. He
is survived by his sister, one son,
three daughters, two stepchildren,
five grandchildren and three
step-grandchildren.

’50

H. William Schmidt, 91, of King
of Prussia, Pa., died Aug. 21, 2012.
Schmidt, a pathologist, was retired
from Montgomery Hospital in
Norristown, Pa. He is survived by
his wife, Marina; his son, Mark;
and two grandchildren.

’54

Bernard B. Borkowski, 86, of
New Hope, Pa., died July 19, 2012.
He completed his internship in
general surgery and residency in
general, vascular and thoracic
surgery at Jefferson and remained
on the medical staff until 1973.
He retired in 1993 as an emergency department physician at
Grandview Hospital in Sellersville,
Pa. Borkowski is survived by his
wife, Barbara, a 1958 Jefferson
diploma nursing graduate; and
two daughters.

’57

Bertram H. Frohman, 84, of
Yardley, Pa., died Aug. 10, 2012.
After serving in the Korean War,
Frohman established a family
medicine practice in Trenton,
N.J., and later in Hamilton, N.J.,
serving the community for over 50
years. He is survived by his wife,
Mary; and seven stepchildren.

’58

William Joseph Thomas, 79, of
Hyannis, Mass., died Oct. 4, 2012.
After graduating from JMC, Thomas
joined the U.S. Navy and established
a distinguished career in adult
psychiatry. He worked at several
hospitals in addition to maintaining
a large private practice in Norwood
and Dover, Mass., for more than 20
years. A lifelong lover of music,
Thomas was an accomplished pianist.
He is survived by his wife, Grace A.
Murphy; and four children.

’65

Albert A. Dubin, 85, of Gilbert,
Ariz., died Aug. 25, 2012. Dubin is
survived by his daughter, Lisa; his
son, Michael; eight grandchildren;
and one great-grandchild.

’69

Benjamin P. Seltzer, 67, of New
Orleans, La., died Oct. 22, 2012.
Seltzer was a neurologist who
researched Alzheimer’s disease
and taught at the medical schools
of Harvard, Boston University
and Tulane, which he left after
Hurricane Katrina. He returned
to Harvard and the Boston VA
before becoming director of
the Program in Cognitive and
Behavioral Neurology at Barrow
Neurological Institute in Phoenix.
He served on the Scientific
Advisory Board of the Arizona
Alzheimer’s Consortium. Seltzer
is survived by his wife, Natalie; his
mother, Sylvia; a sister, Marjorie
Stanek, MD, who is on the faculty
at Jefferson; his children, Daniel,
Jennifer, Peter and Nathan; and
two grandchildren.

Post-Graduate
’71

Shlomo Friedman, of Dallas, died
Feb.12, 2012, of natural causes.
Friedman was a pediatrics resident
at Jefferson from 1968 to 1971 and
a Cardeza Research Fellow from
1971 to 1972.
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The

By Numbers
JMC Alumni Online Community
In fall 2011, JMC launched a private online networking community strictly for alumni. The site not only publishes
Jefferson news and event information but also enables grads and post-grads to create personal profiles and connect
with peers and classmates for both social and professional reasons. You control your profile and decide how much
information to share, from contact information to photographs to LinkedIn profiles.
The community is constantly changing and expanding. Visit connect.jefferson.edu/medicalcollege to join and explore.

JMC graduates listed in the
community’s online directory:
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Now it’s easier than
ever to stay connected!
Follow these easy steps
t o g e t s ta r t e d .
1. Visit connect.jefferson.edu and select the MEDICALCOLLEGE
community in the top bar.
2. Click “register now” in the upper right-hand corner.
3. Fill in your name to search for your record.
4. Enter your constituent ID. Not sure what it is?
It’s right above your name in the mailing label on this page.
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Mr. and Mrs. Thomas Jefferson
PO Box 123
Philadelphia, PA 19107-0123

5. Take a few minutes to set up your profile.
6. Simply click “login” every time you visit in the future.

Explore tools and resources at connect.jefferson.edu/medicalcollege today!

